Loading…

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells

BACKGROUND Lipocalin‐2 (LCN2) is a member of the lipocalin superfamily, and it has an important role in the regulation of cellular oncogenesis and apoptosis. However, the role for LCN2 in prostate cancer remains unclear. METHOD LCN2 expression has been determined by Western blotting, qRT‐PCR, and im...

Full description

Saved in:
Bibliographic Details
Published in:The Prostate 2013-09, Vol.73 (12), p.1281-1290
Main Authors: Tung, Min-Che, Hsieh, Shu-Ching, Yang, Shun-Fa, Cheng, Chun-Wen, Tsai, Rong-Tzong, Wang, Shao-Chuan, Huang, Min-Hsien, Hsieh, Yi-Hsien
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Lipocalin‐2 (LCN2) is a member of the lipocalin superfamily, and it has an important role in the regulation of cellular oncogenesis and apoptosis. However, the role for LCN2 in prostate cancer remains unclear. METHOD LCN2 expression has been determined by Western blotting, qRT‐PCR, and immunohistochemistry in the human prostate cell lines PC3, DU145, LNCaP, and 22Rv, and in human prostate tissue array. In this study, we identified shRNA‐LCN2 to determine the role of LCN2 in prostate‐cancer cell proliferation, migration, and invasion. Cell proliferative ability was measured by MTT, colony‐formation, and cell‐cycle analysis. The role of LCN2 in prostate‐cancer cell migration and invasion was analyzed by cell‐migration assay and Matrigel invasion assay. The effect of LCN2 knockdown on prostate tumor growth was assessed in a subcutaneous xenograft model. RESULTS LCN2 protein and mRNA expression are higher in PC3 and DU145 cells than in LNCaP and 22Rv cells, and prostate cancer tissue correlated significantly with tumor differentiation (P 
ISSN:0270-4137
1097-0045
DOI:10.1002/pros.22670